Robert Wenslow is a seasoned drug development scientist with a strong background in pharmaceutical characterization. He has extensive experience in all solid-state research issues relating to the pharmaceutical industry. In his role at Crystal Pharmatech, he and his team will work with you to speed up your drug discovery, research and development needs at a containable cost. Before joining Crystal Pharmatech, Robert spent 14 years at Merck & Co. His group supported, on average, 30 drug development projects per year. They contributed to salt and polymorph selection, crystallization development and optimization, preparation of registration documents, and specification setting in the area of solid-state support for both bulk drug substance and drug product.
Robert received his Ph.D. in Analytical Chemistry from The Pennsylvania State University; has presented as invited lecturer at over 10 conferences; has published over 25 peer reviewed journal articles, and is co-author on over 10 patents. Robert also spent two years at Merck’s Manufacturing site in Ballydine, Ireland where he was responsible for creating and leading the first research based Analytical Science Group in the Merck Manufacturing Network. The group provides drug substance and drug product analytical development and testing for late stage drug candidates.